USP25 and head and neck squamous cell carcinoma: To assess the effect of USP25 and the therapeutic efficacy of anti-PD-1 antibodies on HNSCC in vivo, we developed a mouse model in which MOC1NC or MOC1OE-USP25 cells were implanted.